These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Acid-base catalysis by UDP-galactose 4-epimerase: correlations of kinetically measured acid dissociation constants with thermodynamic values for tyrosine 149. Berger E; Arabshahi A; Wei Y; Schilling JF; Frey PA Biochemistry; 2001 Jun; 40(22):6699-705. PubMed ID: 11380265 [TBL] [Abstract][Full Text] [Related]
27. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity. Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142 [TBL] [Abstract][Full Text] [Related]
28. Yeast cells as an assay system for in vivo O-GlcNAc modification. Nakanishi H; Li F; Han B; Arai S; Gao XD Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870 [TBL] [Abstract][Full Text] [Related]
29. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK. Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565 [TBL] [Abstract][Full Text] [Related]
30. Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia. Maceratesi P; Daude N; Dallapiccola B; Novelli G; Allen R; Okano Y; Reichardt J Mol Genet Metab; 1998 Jan; 63(1):26-30. PubMed ID: 9538513 [TBL] [Abstract][Full Text] [Related]
31. Assessment of galactose-1-phosphate uridyltransferase activity in cells and tissues. Brophy ML; Murphy JE; Bell RD J Biol Methods; 2021; 8(2):e149. PubMed ID: 34258307 [TBL] [Abstract][Full Text] [Related]
32. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway. Zhang P; Wang C; Ma T; You S Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480 [TBL] [Abstract][Full Text] [Related]
33. Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans. Ghosh SK; Bond MR; Love DC; Ashwell GG; Krause MW; Hanover JA Front Endocrinol (Lausanne); 2014; 5():197. PubMed ID: 25505447 [TBL] [Abstract][Full Text] [Related]
34. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia. Timson DJ; Lindert S Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289 [TBL] [Abstract][Full Text] [Related]
35. Too sweet to resist: Control of immune cell function by O-GlcNAcylation. de Jesus T; Shukla S; Ramakrishnan P Cell Immunol; 2018 Nov; 333():85-92. PubMed ID: 29887419 [TBL] [Abstract][Full Text] [Related]
36. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis. Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569 [TBL] [Abstract][Full Text] [Related]
37. Novel activity of UDP-galactose-4-epimerase for free monosaccharide and activity improvement by active site-saturation mutagenesis. Kim HJ; Kang SY; Park JJ; Kim P Appl Biochem Biotechnol; 2011 Feb; 163(3):444-51. PubMed ID: 20717852 [TBL] [Abstract][Full Text] [Related]
38. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer. Starska K; Forma E; Brzezińska-Błaszczyk E; Lewy-Trenda I; Bryś M; Jóźwiak P; Krześlak A Clin Exp Med; 2015 Nov; 15(4):455-68. PubMed ID: 25315705 [TBL] [Abstract][Full Text] [Related]
40. Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway. Zhang B; Zhou P; Li X; Shi Q; Li D; Ju X Am J Cancer Res; 2017; 7(6):1337-1349. PubMed ID: 28670495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]